Covered recipient · General Payments record
MARGARET GAVOR
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2024
$13,642.66
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $8,555.00 | 2 |
| Travel and Lodging | $3,791.97 | 6 |
| Food and Beverage | $806.87 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $13,015.78 | 15 |
| GlaxoSmithKline, LLC. | $40.48 | 3 |
| PFIZER INC. | $29.73 | 1 |
| DEXCOM, INC. | $22.26 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.20 | 1 |
| Acerta Pharma LLC | $14.02 | 1 |
| Lilly USA, LLC | $13.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $14.02 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105743002 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.20 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117860335 | CMS |
| Dexcom, Inc. | $22.26 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153318940 | CMS |
| GlaxoSmithKline, LLC. | $13.43 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116634768 | CMS |
| GlaxoSmithKline, LLC. | $13.58 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116488581 | CMS |
| GlaxoSmithKline, LLC. | $13.47 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116626050 | CMS |
| Lilly USA, LLC | $13.37 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135164909 | CMS |
| Novo Nordisk Inc | $16.84 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097236024 | CMS |
| Novo Nordisk Inc | $273.23 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096626077 | CMS |
| Novo Nordisk Inc | $3,987.50 | 04/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1097322902 | CMS |
| Novo Nordisk Inc | $665.79 | 04/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1097496937 | CMS |
| Novo Nordisk Inc | $1,383.46 | 04/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1097499064 | CMS |
| Novo Nordisk Inc | $133.20 | 04/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1097499415 | CMS |
| Novo Nordisk Inc | $124.84 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097235172 | CMS |
| Novo Nordisk Inc | $20.00 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096909083 | CMS |
| Novo Nordisk Inc | $236.20 | 09/20/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1096877244 | CMS |
| Novo Nordisk Inc | $199.95 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097322907 | CMS |
| Novo Nordisk Inc | $4,567.50 | 09/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1097323057 | CMS |
| Novo Nordisk Inc | $496.50 | 09/20/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1097495675 | CMS |
| Novo Nordisk Inc | $876.82 | 09/20/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1097838462 | CMS |
| Novo Nordisk Inc | $18.97 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096892429 | CMS |
| Novo Nordisk Inc | $14.98 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096785424 | CMS |
| PFIZER INC. | $29.73 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131860255 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.